Safety and efficacy of doxycycline in the treatment of rosacea

Author(s): Sheila Valentín | Adisbeth Morales | Jorge L Sánchez | et al

Journal: Clinical, Cosmetic and Investigational Dermatology ISSN 1178-7015
Volume: 2009; Issue: default; Start page: 129; Date: 2009;
Original page

ABSTRACT
Sheila Valentín, Adisbeth Morales, Jorge L Sánchez, Abimael RiveraDepartment of Dermatology, University of Puerto Rico, School of Medicine, San Juan, Puerto RicoAbstract: Rosacea is a common, chronic, skin condition characterized by recurrent episodes of facial flushing, transient or persistent erythema, papules, pustules, and telangiectasias, in a symmetrical facial distribution. The etiology of rosacea remains unknown and this condition represents a therapeutic challenge because of its chronic nature, progression, potential for disfigurement and psychological impact. Although there is no curative therapy for rosacea, the most widely used systemic agents are oral tetracycline derivatives, including tetracycline, doxycycline, and minocycline. This article reviews the available evidence for the use of doxycycline, a second-generation tetracycline, in the treatment or rosacea.Keywords: rosacea, doxycyline, tetracyclines

Click to add the current page to your list

Add to my list

You can add Journals, Articles or Searches to your list. Icons for adding can be found on the corresponding pages.

My list